FDA Stay Informed RSS
- FDA Updates and Press Announcements on Angiotensin II Receptor Blocker (ARB) Recalls (Valsartan, Losartan, and Irbesartan) September 20, 2019Get updates on the recallsFDA
FiercePharma News RSS
- Novo Nordisk wins FDA green light for 'holy grail' diabetes drug Rybelsus September 20, 2019Novo Nordisk’s Rybelsus—or, as industry watchers know it, oral semaglutide—snared its FDA nod Friday to control blood sugar in Type 2 diabetes patients. And with the drug's stellar data and head-to-head study wins against top products in the field, the green light is expected to majorly shake things up.Carly Helfand
Leave a Reply
Want to join the discussion?Feel free to contribute!